Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Creatine Kinase Market Size study by Type (MM, BB, MB, MiMi), by Application (Hospital, Laboratory, Others) and Regional Forecasts 2020-2027

  • BIZ3921547
  • 200 Pages
  • June 2020
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Creatine Kinase Market is valued approximately at USD XXX million in 2019 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2020-2027. Creatine kinase (also referred as phosphocreatine kinase or creatine phosphokinase), is a protein enzyme, which is recognized through different types tissues and cell. Creatine kinase catalyzes the transformation of creatine and uses adenosine triphosphate (ATP) to produce phosphocreatine (PCr) and adenosine diphosphate (ADP). Creatine kinase enzyme reaction is revocable, and thus, ATP can be produced from ADP and PCr. It is usually found in skeletal muscles and heart and in smaller amounts in the brain. It works with bones to move and give strength and power to the individual’s body. Growing patient population suffering from myocardial infarction, favorable reimbursement scenario and increasing healthcare expenditure & funding are the few factors responsible for high CAGR of the market over the forecast period. For instance, according to the Centers for Medicare & Medicaid Services (CMS), the national health expenditure was estimated around 4.8% in 2019, an increase from 4.4% growth in 2018, and to reach almost USD 3.8 trillion. Also, as per Statista, the public health expenditure in India was about 1.58 trillion Indian rupees in 2018. This factor would boost the demand for Creatine Kinase in the global market thereby, aiding to the market growth in the forthcoming years. Furthermore, rapid launch of novel creatine kinase reagents to enhance the creatine kinase testing is further contemplating the market growth around the world. With the disruption in product supply chain because of COVID-19 crisis, several leading suppliers are under lockdown to prevent the spread of novel coronavirus therefore, the industry is recently faced several significant challenges with concerns to ramping up the manufacturing facilities to reduce the risk of supply shortage. Thus, this factor is expected to create a major obstacle to market growth in the recent year. However, un favorable regulatory guideline for product approval in some of the developed and developing nations is always being considered as one of the major restraining factors to the market growth during the forecast period of 2020-2027.

The regional analysis of global Creatine Kinase market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the presence of strong and advanced healthcare facilities, coupled with increasing product launch of new creatine kinase reagents testing kits in the region. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027, due to growing healthcare expenditure in the countries such as China and India.

Major market player included in this report are:

Beckman Coulter Inc.

F. Hoffmann-La Roche AG

Abbott Laboratories

Siemens Healthcare AG

LSI Medicine Corp.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

MM

BB

MB

MiMi

By Application:

Hospital

Laboratory

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018

Base year – 2019

Forecast period – 2020 to 2026

Target Audience of the Global Creatine Kinase Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)

1.2.1. Creatine Kinase Market, by Region, 2018-2027 (USD Million)

1.2.2. Creatine Kinase Market, by Type, 2018-2027 (USD Million)

1.2.3. Creatine Kinase Market, by Application, 2018-2027 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Creatine Kinase Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Creatine Kinase Market Dynamics

3.1. Creatine Kinase Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Creatine Kinase Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Creatine Kinase Market, by Type

5.1. Market Snapshot

5.2. Global Creatine Kinase Market by Type, Performance - Potential Analysis

5.3. Global Creatine Kinase Market Estimates & Forecasts by Type 2017-2027 (USD Million)

5.4. Creatine Kinase Market, Sub Segment Analysis

5.4.1. MM

5.4.2. BB

5.4.3. MB

5.4.4. MiMi

Chapter 6. Global Creatine Kinase Market, by Application

6.1. Market Snapshot

6.2. Global Creatine Kinase Market by Application, Performance - Potential Analysis

6.3. Global Creatine Kinase Market Estimates & Forecasts by Application 2017-2027 (USD Million)

6.4. Creatine Kinase Market, Sub Segment Analysis

6.4.1. Hospital

6.4.2. Laboratory

6.4.3. Others

Chapter 7. Global Creatine Kinase Market, Regional Analysis

7.1. Creatine Kinase Market, Regional Market Snapshot

7.2. North America Creatine Kinase Market

7.2.1. U.S. Creatine Kinase Market

7.2.1.1. Type breakdown estimates & forecasts, 2017-2027

7.2.1.2. Application breakdown estimates & forecasts, 2017-2027

7.2.2. Canada Creatine Kinase Market

7.3. Europe Creatine Kinase Market Snapshot

7.3.1. U.K. Creatine Kinase Market

7.3.2. Germany Creatine Kinase Market

7.3.3. Rest of Europe Creatine Kinase Market

7.4. Asia-Pacific Creatine Kinase Market Snapshot

7.4.1. China Creatine Kinase Market

7.4.2. India Creatine Kinase Market

7.4.3. Japan Creatine Kinase Market

7.4.4. Rest of Asia Pacific Creatine Kinase Market

7.5. Latin America Creatine Kinase Market Snapshot

7.5.1. Brazil Creatine Kinase Market

7.5.2. Mexico Creatine Kinase Market

7.6. Rest of The World Creatine Kinase Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Beckman Coulter Inc.

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. F. Hoffmann-La Roche AG

8.2.3. Abbott Laboratories

8.2.4. Siemens Healthcare AG

8.2.5. LSI Medicine Corp.

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. GLOBAL CREATINE KINASE MARKET, REPORT SCOPE

TABLE 2. GLOBAL CREATINE KINASE MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD MILLION)

TABLE 3. GLOBAL CREATINE KINASE MARKET ESTIMATES & FORECASTS BY TYPE 2017-2027 (USD MILLION)

TABLE 4. GLOBAL CREATINE KINASE MARKET ESTIMATES & FORECASTS BY APPLICATION 2017-2027 (USD MILLION)

TABLE 5. GLOBAL CREATINE KINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 6. GLOBAL CREATINE KINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 7. GLOBAL CREATINE KINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 8. GLOBAL CREATINE KINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 9. GLOBAL CREATINE KINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 10. GLOBAL CREATINE KINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 11. GLOBAL CREATINE KINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 12. GLOBAL CREATINE KINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 13. GLOBAL CREATINE KINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 14. GLOBAL CREATINE KINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 15. U.S. CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 16. U.S. CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 1. U.S. CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 2. CANADA CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 3. CANADA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 4. CANADA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 5. UK CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 6. UK CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 7. UK CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 8. GERMANY CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 9. GERMANY CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 10. GERMANY CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 11. ROE CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 12. ROE CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 13. ROE CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 14. CHINA CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 15. CHINA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 16. CHINA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 17. INDIA CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 18. INDIA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 19. INDIA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 20. JAPAN CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 21. JAPAN CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 22. JAPAN CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 23. ROAPAC CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 24. ROAPAC CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 25. ROAPAC CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 26. BRAZIL CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 27. BRAZIL CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 28. BRAZIL CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 29. MEXICO CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 30. MEXICO CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 31. MEXICO CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 32. ROLA CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 33. ROLA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 34. ROLA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 35. ROW CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)

TABLE 36. ROW CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 37. ROW CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)

TABLE 38. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CREATINE KINASE MARKET

TABLE 39. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CREATINE KINASE MARKET

TABLE 40. YEARS CONSIDERED FOR THE STUDY

TABLE 41. EXCHANGE RATES CONSIDERED

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390